Zhejiang Hisun Pharmaceutical Co., Ltd. Stock Price

SHSE:600267 Community·CN¥12.3b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

600267 Share Price Performance

CN¥10.65

1.51 (16.52%)

CN¥10.65

1.51 (16.52%)

CN¥10.65

Sat, 23 May 26

Share Pricen/a

600267 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet established dividend payer.

2 Risks

2 Rewards

View Full Analysis

Zhejiang Hisun Pharmaceutical Co., Ltd. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 0.61
: 45.78%
: 6.81%
: 23.6%

View Full Analysis

About 600267

Founded: 1956
Employees: 8751
CEO: Weihong Xiao
WebsiteView website: www.hisunpharm.com

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956 and is headquartered in Taizhou, China.